title: Survival of patients with non-small-cell lung cancer after a diagnosis of brain metastases.
abstract: BACKGROUND
  The prognosis of patients with brain metastases from non-small-cell lung cancer (nsclc) is poor. However, some reports suggest that patients with brain metastases at the time of initial diagnosis have a more favourable survival than do patients with advanced nsclc without brain metastases.
  
  
  METHODS
  In a retrospective cohort of all new lung cancer patients seen at a Canadian tertiary centre between July 2005 and June 2007, we examined survival after a diagnosis of brain metastases for patients with brain metastases at initial diagnosis and patients who developed brain metastases later in their illness.
  
  
  RESULTS
  During the 2-year period, 91 of 878 patients (10.4%) developed brain metastases. Median age in this cohort was 64 years. In 45, brain metastases were present at initial diagnosis, and in 46, brain metastases developed later in the course of the illness. Median survival in the entire cohort was 7.8 months. Survival after the diagnosis of brain metastases was similar for patients with brain metastases at diagnosis and later in the illness (4.8 months vs. 3.7 months, p = 0.53). As a result, patients who developed brain metastases later in their illness had a longer overall survival than did patients with brain metastases at diagnosis (9.8 months vs. 4.8 months). Among patients who received chemotherapy, the survival of patients with brain metastases at diagnosis was still poor (6.2 months).
  
  
  CONCLUSIONS
  Our data show limited survival in patients with brain metastases from nsclc. Careful patient selection for more aggressive treatment approaches is necessary.
authors.affiliation: Comprehensive Cancer Centre, King Fahad Medical City, Riyadh, Saudi Arabia.
authors.forename: A
authors.initials: A
authors.lastname: Ali
authors.forename: J R
authors.initials: JR
authors.lastname: Goffin
authors.forename: A
authors.initials: A
authors.lastname: Arnold
authors.forename: P M
authors.initials: PM
authors.lastname: Ellis
keywords: Early prognosis; chemotherapy; late prognosis; whole-brain radiation
references.citation: J Neurol Neurosurg Psychiatry. 1994 Aug;57(8):950-6
references.pmid: 8057119
references.citation: N Engl J Med. 1990 Feb 22;322(8):494-500
references.pmid: 2405271
references.citation: Cancer Treat Rev. 1984 Jun;11(2):157-86
references.pmid: 6388835
references.citation: J Neurosurg. 1993 Aug;79(2):210-6
references.pmid: 8331402
references.citation: Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):745-51
references.pmid: 9128946
references.citation: J Neurosurg. 2001 Oct;95(4):595-600
references.pmid: 11596953
references.citation: J Clin Oncol. 2005 Sep 1;23(25):6207-19
references.pmid: 16135488
references.citation: Ann Oncol. 2001 Jan;12(1):59-67
references.pmid: 11249050
references.citation: Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):218-24
references.pmid: 15337559
references.citation: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references.pmid: 15761078
references.citation: Int J Radiat Oncol Biol Phys. 2000 Mar 15;46(5):1155-61
references.pmid: 10725626
references.citation: J Neurooncol. 2009 May;92(3):275-82
references.pmid: 19357955
references.citation: J Neurooncol. 2010 Jan;96(1):115-42
references.pmid: 19957013
references.citation: Ann Neurol. 1993 Jun;33(6):583-90
references.pmid: 8498838
references.citation: Lung Cancer. 2004 Aug;45 Suppl 2:S253-7
references.pmid: 15552807
references.citation: Clin Lung Cancer. 2009 May;10(3):174-9
references.pmid: 19443337
references.citation: Lancet. 2004 May 22;363(9422):1665-72
references.pmid: 15158627
references.citation: Lung Cancer. 2001 Aug-Sep;33(2-3):143-54
references.pmid: 11551409
references.citation: N Engl J Med. 2002 Jan 10;346(2):92-8
references.pmid: 11784875
references.citation: Lung Cancer. 2009 Jan;63(1):140-5
references.pmid: 18556086
references.citation: Lung Cancer. 2003 Dec;42(3):327-33
references.pmid: 14644521
references.citation: Cancer Invest. 2002;20(3):293-302
references.pmid: 12025223
references.citation: Cancer Invest. 2008 Apr-May;26(3):250-5
references.pmid: 18317965
references.citation: J Neurosurg. 2008 Dec;109 Suppl:77-86
references.pmid: 19123892
references.citation: Ann Oncol. 2011 Nov;22(11):2466-2470
references.pmid: 21321089
references.citation: J Neurosurg. 1995 Oct;83(4):605-16
references.pmid: 7674008
references.citation: J Clin Oncol. 2003 Aug 15;21(16):3016-24
references.pmid: 12837811
references.citation: J Proteome Res. 2011 Jul 1;10(7):3089-97
references.pmid: 21574647
references.citation: J Neurosurg. 1996 May;84(5):748-54
references.pmid: 8622147